The Role of NLRP3 and IL-1β in the Pathogenesis of Inflammatory Bowel Disease

It is logical to assume that a major pro-inflammatory mechanism, i.e., the NLRP3 inflammasome would play a prominent role in the pathogenesis of the Inflammatory Bowel Disease (IBD) in humans. However, while both studies of murine models of gut disease and patients provide data that the main cytokine product generated by this inflammasome, IL-1β, does in fact contribute to inflammation in IBD, there is no evidence that IL-1β plays a decisive or prominent role in “ordinary” patients with IBD (Crohn's disease). On the other hand, there are several definable point mutations that result in over-active NLRP3 inflammasome activity and in these cases, the gut inflammation is driven by IL-1β and is treatable by biologic agents that block the effects of this cytokine.

[1]  Andrew J. Oler,et al.  Loss-of-function CARD8 mutation causes NLRP3 inflammasome activation and Crohn’s disease , 2018, The Journal of clinical investigation.

[2]  R. Flavell,et al.  Shaping of Intestinal Microbiota in Nlrp6- and Rag2-Deficient Mice Depends on Community Structure. , 2017, Cell reports.

[3]  Liping Zhao,et al.  Remodelling of the gut microbiota by hyperactive NLRP3 induces regulatory T cells to maintain homeostasis , 2017, Nature Communications.

[4]  J. Raes,et al.  Nlrp6‐ and ASC‐Dependent Inflammasomes Do Not Shape the Commensal Gut Microbiota Composition , 2017, Immunity.

[5]  R. Flavell,et al.  Microbiota Normalization Reveals that Canonical Caspase-1 Activation Exacerbates Chemically Induced Intestinal Inflammation. , 2017, Cell reports.

[6]  M. Mack,et al.  Myeloid-derived miR-223 regulates intestinal inflammation via repression of the NLRP3 inflammasome , 2017, The Journal of experimental medicine.

[7]  P. Schloss,et al.  NLRP6 Protects Il10-/- Mice from Colitis by Limiting Colonization of Akkermansia muciniphila. , 2017, Cell reports.

[8]  Wenqing Gao,et al.  Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death. , 2017, Trends in biochemical sciences.

[9]  E. Elinav,et al.  NLRP6: A Multifaceted Innate Immune Sensor. , 2017, Trends in immunology.

[10]  S. Plevy,et al.  The intracellular innate immune sensor NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth , 2017, Nature Immunology.

[11]  S. Brant,et al.  The Pathogenic Role of NLRP3 Inflammasome Activation in Inflammatory Bowel Diseases of Both Mice and Humans , 2016, Journal of Crohn's & colitis.

[12]  C. Klein,et al.  Interleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency. , 2016, Gastroenterology.

[13]  B. Becher,et al.  NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22. , 2016, The Journal of clinical investigation.

[14]  I. Amit,et al.  Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling , 2015, Cell.

[15]  E. Elinav,et al.  Epithelial IL-18 Equilibrium Controls Barrier Function in Colitis , 2015, Cell.

[16]  C. Abraham,et al.  A TPL2 (MAP3K8) disease-risk polymorphism increases TPL2 expression thereby leading to increased pattern recognition receptor-initiated caspase-1 and caspase-8 activation, signalling and cytokine secretion , 2015, Gut.

[17]  M. Levings,et al.  Tr1 Cells, but Not Foxp3+ Regulatory T Cells, Suppress NLRP3 Inflammasome Activation via an IL-10–Dependent Mechanism , 2015, The Journal of Immunology.

[18]  K. Boini,et al.  Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector? , 2015, Antioxidants & redox signaling.

[19]  G. Núñez,et al.  Distinct Commensals Induce Interleukin-1β via NLRP3 Inflammasome in Inflammatory Monocytes to Promote Intestinal Inflammation in Response to Injury. , 2015, Immunity.

[20]  E. Kay,et al.  Protective Role for Caspase-11 during Acute Experimental Murine Colitis , 2014, The Journal of Immunology.

[21]  M. Lamkanfi,et al.  Caspase-11 is expressed in the colonic mucosa and protects against dextran sodium sulphate-induced colitis , 2014, Mucosal Immunology.

[22]  R. Xavier,et al.  IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans , 2014, Proceedings of the National Academy of Sciences.

[23]  Zihai Li,et al.  Inflammasome activation plays an important role in the development of spontaneous colitis , 2016 .

[24]  C. Dinarello,et al.  Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice , 2013, Gut.

[25]  Anna K Rieger,et al.  NLRP3 Inflammasome Activity Is Negatively Controlled by miR-223 , 2012, The Journal of Immunology.

[26]  H. Lehr,et al.  Protective and Aggravating Effects of Nlrp3 Inflammasome Activation in IBD Models: Influence of Genetic and Environmental Factors , 2012, Digestive Diseases.

[27]  Burkhard Becher,et al.  IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4+ Th17 cells , 2012, The Journal of experimental medicine.

[28]  K. Tracey,et al.  Novel role of PKR in inflammasome activation and HMGB1 release , 2012, Nature.

[29]  H. Herfarth,et al.  NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling. , 2012, Immunity.

[30]  C. Duckett,et al.  An inactivating caspase 11 passenger mutation originating from the 129 murine strain in mice targeted for c-IAP1 , 2012, The Biochemical journal.

[31]  Richard A. Flavell,et al.  Inflammasomes in health and disease , 2012, Nature.

[32]  D. Green,et al.  The NOD-like receptor NLRP12 attenuates colon inflammation and tumorigenesis. , 2011, Cancer cell.

[33]  Rob Knight,et al.  Interleukin-1β (IL-1β) promotes susceptibility of Toll-like receptor 5 (TLR5) deficient mice to colitis , 2011, Gut.

[34]  Yan Li,et al.  NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis , 2011, Inflammatory bowel diseases.

[35]  Richard A. Flavell,et al.  NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis , 2011, Cell.

[36]  H. Herfarth,et al.  The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer , 2010, The Journal of experimental medicine.

[37]  J. Tschopp,et al.  Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome , 2010, Gut.

[38]  M. Kastan,et al.  The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. , 2010, Immunity.

[39]  N. Beauchemin,et al.  Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. , 2010, Immunity.

[40]  Gisen Kim,et al.  Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis , 2009, Nature Immunology.

[41]  J. López-Miranda,et al.  [Influence of genetic and environmental factors on lipid metabolism and cardiovascular risk associated with the apoE gene]. , 2006, Medicina clinica.

[42]  D. Green,et al.  Enhanced bacterial clearance and sepsis resistance in caspase-12-deficient mice , 2006, Nature.

[43]  O. H.,et al.  Contrasting Action of IL-12 and IL-18 in the Development of Dextran Sodium Sulphate Colitis in Mice , 2003 .

[44]  P. Simon,et al.  Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease. , 1990, Gut.

[45]  D. Xia,et al.  Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome. , 2016, Immunity.